Sign inJoin waitlistJoin the waitlist

Amber Cipriani

PPMH Pharmacogenomics Lead · University of North Carolina Hospitals

Credentials: ·

History

University of North Carolina Hospitals
Present

Research

Cardiovascular Effects of the MEK Inhibitor, Trametinib: A Case Report, Literature Review, and Consideration of Mechanism
Case report · Cardiovascular Toxicology · 2017 · 80 citations
Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma
Review · Annals of Pharmacotherapy · 2014 · First of 3 authors · 31 citations
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
Clinical and Translational Science · 2022 · 25 citations

JB
Jill Bates
4 papers
Amanda Elchynski
2 papers · 2 as a fellow
Amber Beitelshees
2 papers
Brian Jensen
2 papers
DM
Danielle McCamey
2 papers
David Oslin
2 papers
Jeffrey Bishop
2 papers
Pawel Mroz
2 papers · 2 as a fellow
SS
Sandra Swain
2 papers
Sara Van Driest
2 papers
Cindy O'Bryant
1 paper
David Ollila
1 paper